IL126199A - Pharmaceutical preparation for administration through the nose for preventive treatment for delayed vomiting - Google Patents
Pharmaceutical preparation for administration through the nose for preventive treatment for delayed vomitingInfo
- Publication number
- IL126199A IL126199A IL12619997A IL12619997A IL126199A IL 126199 A IL126199 A IL 126199A IL 12619997 A IL12619997 A IL 12619997A IL 12619997 A IL12619997 A IL 12619997A IL 126199 A IL126199 A IL 126199A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- composition according
- daily dosage
- hours
- metoclopramide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/616,121 US5760086A (en) | 1996-03-14 | 1996-03-14 | Nasal administration of agents for treatment of delayed onset emesis |
| PCT/US1997/003974 WO1997033573A1 (en) | 1996-03-14 | 1997-03-13 | Nasal administration of agents for treatment of delayed onset emesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL126199A0 IL126199A0 (en) | 1999-05-09 |
| IL126199A true IL126199A (en) | 2004-06-01 |
Family
ID=24468120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12619997A IL126199A (en) | 1996-03-14 | 1997-03-13 | Pharmaceutical preparation for administration through the nose for preventive treatment for delayed vomiting |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5760086A (de) |
| EP (1) | EP0891186B1 (de) |
| JP (1) | JP2000507234A (de) |
| KR (1) | KR100420673B1 (de) |
| CN (1) | CN1217657A (de) |
| AT (1) | ATE489137T1 (de) |
| AU (1) | AU707467B2 (de) |
| BG (1) | BG102780A (de) |
| CA (1) | CA2248968C (de) |
| CZ (1) | CZ289797B6 (de) |
| DE (1) | DE69740060D1 (de) |
| DK (1) | DK0891186T3 (de) |
| EE (1) | EE03665B1 (de) |
| ES (1) | ES2357520T3 (de) |
| IL (1) | IL126199A (de) |
| NO (1) | NO984245L (de) |
| NZ (1) | NZ331991A (de) |
| PL (1) | PL328940A1 (de) |
| PT (1) | PT891186E (de) |
| RU (1) | RU2181588C2 (de) |
| SK (1) | SK282695B6 (de) |
| UA (1) | UA57733C2 (de) |
| WO (1) | WO1997033573A1 (de) |
| YU (1) | YU40398A (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770262B2 (en) | 2000-03-30 | 2004-08-03 | Questcor Pharmaceuticals, Inc. | Nasal administration of agents for the treatment of gastroparesis |
| WO2010054932A1 (en) * | 2008-11-11 | 2010-05-20 | Unilever Nv | Tea composition |
| US20130213393A1 (en) | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| CA2984736C (en) | 2008-12-22 | 2022-07-05 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| US20110165143A1 (en) * | 2010-01-06 | 2011-07-07 | The Regents Of The University Of Colorado, A Body Corporate | Modulation of caspases and therapeutical applications |
| DK2747561T3 (en) | 2011-08-25 | 2018-08-06 | Evoke Pharma Inc | TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS |
| FR2980976B1 (fr) * | 2011-10-10 | 2015-10-16 | Mohamed Skiba | Composition pharmaceutique pour l'administration par voie nasale de la metopimazine |
| CN104606136A (zh) * | 2015-01-06 | 2015-05-13 | 中国人民解放军军事医学科学院毒物药物研究所 | 甲氧氯普胺鼻腔喷雾剂、其制备方法及用途 |
| CA3047088A1 (en) | 2016-12-15 | 2018-06-21 | Evoke Pharma, Inc. | Treatment of moderate and severe gastroparesis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4624965A (en) * | 1984-11-15 | 1986-11-25 | Nastech Pharmaceutical Co., Inc. | Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same |
-
1996
- 1996-03-14 US US08/616,121 patent/US5760086A/en not_active Expired - Lifetime
-
1997
- 1997-03-13 IL IL12619997A patent/IL126199A/en not_active IP Right Cessation
- 1997-03-13 KR KR10-1998-0707237A patent/KR100420673B1/ko not_active IP Right Cessation
- 1997-03-13 DK DK97915060.4T patent/DK0891186T3/da active
- 1997-03-13 AT AT97915060T patent/ATE489137T1/de active
- 1997-03-13 CA CA002248968A patent/CA2248968C/en not_active Expired - Lifetime
- 1997-03-13 PT PT97915060T patent/PT891186E/pt unknown
- 1997-03-13 RU RU98118578/14A patent/RU2181588C2/ru active IP Right Revival
- 1997-03-13 NZ NZ331991A patent/NZ331991A/xx not_active IP Right Cessation
- 1997-03-13 PL PL97328940A patent/PL328940A1/xx unknown
- 1997-03-13 CN CN97194427A patent/CN1217657A/zh active Pending
- 1997-03-13 JP JP9532838A patent/JP2000507234A/ja not_active Ceased
- 1997-03-13 AU AU22102/97A patent/AU707467B2/en not_active Ceased
- 1997-03-13 WO PCT/US1997/003974 patent/WO1997033573A1/en active IP Right Grant
- 1997-03-13 EP EP97915060A patent/EP0891186B1/de not_active Expired - Lifetime
- 1997-03-13 SK SK1259-98A patent/SK282695B6/sk unknown
- 1997-03-13 UA UA98105338A patent/UA57733C2/uk unknown
- 1997-03-13 YU YU40398A patent/YU40398A/sh unknown
- 1997-03-13 DE DE69740060T patent/DE69740060D1/de not_active Expired - Lifetime
- 1997-03-13 EE EE9800295A patent/EE03665B1/xx not_active IP Right Cessation
- 1997-03-13 CZ CZ19982922A patent/CZ289797B6/cs not_active IP Right Cessation
- 1997-03-13 ES ES97915060T patent/ES2357520T3/es not_active Expired - Lifetime
-
1998
- 1998-09-14 NO NO984245A patent/NO984245L/no not_active Application Discontinuation
- 1998-09-18 BG BG102780A patent/BG102780A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO984245L (no) | 1998-11-11 |
| ATE489137T1 (de) | 2010-12-15 |
| BG102780A (en) | 2000-01-31 |
| PL328940A1 (en) | 1999-03-01 |
| ES2357520T3 (es) | 2011-04-27 |
| KR100420673B1 (ko) | 2004-07-23 |
| CA2248968C (en) | 2005-08-02 |
| CA2248968A1 (en) | 1997-09-18 |
| WO1997033573A1 (en) | 1997-09-18 |
| PT891186E (pt) | 2011-02-25 |
| UA57733C2 (uk) | 2003-07-15 |
| JP2000507234A (ja) | 2000-06-13 |
| DK0891186T3 (da) | 2011-03-14 |
| YU40398A (sh) | 2001-07-10 |
| KR19990087763A (ko) | 1999-12-27 |
| EP0891186A4 (de) | 2004-03-31 |
| CZ289797B6 (cs) | 2002-04-17 |
| AU707467B2 (en) | 1999-07-08 |
| EE9800295A (et) | 1999-02-15 |
| EE03665B1 (et) | 2002-04-15 |
| SK125998A3 (en) | 1999-03-12 |
| RU2181588C2 (ru) | 2002-04-27 |
| AU2210297A (en) | 1997-10-01 |
| IL126199A0 (en) | 1999-05-09 |
| EP0891186A1 (de) | 1999-01-20 |
| EP0891186B1 (de) | 2010-11-24 |
| SK282695B6 (sk) | 2002-11-06 |
| CN1217657A (zh) | 1999-05-26 |
| NO984245D0 (no) | 1998-09-14 |
| US5760086A (en) | 1998-06-02 |
| DE69740060D1 (de) | 2011-01-05 |
| NZ331991A (en) | 2000-04-28 |
| CZ292298A3 (cs) | 1999-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5801161A (en) | Pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| CZ187097A3 (cs) | Farmaceutický prostředek | |
| WO1992000743A1 (en) | Use of taurolidine and/or taurultam for the treatment of tumours | |
| US5753712A (en) | Treatment of migraine headaches and formulations | |
| AU707467B2 (en) | Nasal administration of agents for treatment of delayed onset emesis | |
| US5886012A (en) | Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers | |
| US5661142A (en) | Anti-emetic composition | |
| US5925625A (en) | Pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| US5457132A (en) | Kit used in the treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers | |
| EP0938319A1 (de) | Pharmazeutische zubereitung entheltend alendronat und ein die magenentleerung förderndes mittel | |
| NL8105635A (nl) | Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking. | |
| Kauffman et al. | Anaphylaxis upon switching lipid-containing amphotericin B formulations | |
| US4522827A (en) | Method of treating acute pancreatitis with isometheptene | |
| MXPA98007474A (en) | Nasal administration of agents for the treatment of retard attack emesis | |
| US4663345A (en) | Etodolac for treatment of gout | |
| Stratigos et al. | Treatment of gonorrhoea with spectinomycin hydrochloride. | |
| US6693100B1 (en) | Pharmaceutical compositions for treating psoriasis | |
| CA2403674A1 (en) | The use of t3 for treating congestive heart failure | |
| US4716177A (en) | Tolrestat for inhibition of weight gain | |
| US4701467A (en) | Tolrestat as anti-hypertensive agent | |
| EP0488041A2 (de) | Pharmazeutische Zusammensetzung gegen Cytomegalovirusinfektion | |
| JPH04352722A (ja) | 外因性カルシウム及びニカルジピンを含む医薬組成物 | |
| JPS61200917A (ja) | ベタキソロールとニフエジピンとを含有する医薬組成物 | |
| WO2001019358A2 (en) | Use dexrazoxane for treating psoriasis | |
| CZ5821U1 (cs) | Farmaceutický přípravek pro léčení hernofilie a použití hormonu mestranolu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |